Cardiosense Inc. announced this week that it raised $15.1 million in Series A funding.
The round was led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures and Portal Innovations.
The Chicago-based digital health company will use the capital to expand its team, accelerate product development and fund a heart-failure study.
The company also hopes to get regulatory clearance for its CardioTag product,…
